Nuvation Bio Inc - Ordinary Shares - Class A

NYSE:NUVB   3:59:52 PM EDT
9.97
+0.62 (+6.63%)
Earnings Announcements

Nuvation Bio Expects To Submit Up To Five Additional Investigational NDA With U.S. FDA By 2026

Published: 03/11/2021 23:15 GMT
Nuvation Bio Inc - Ordinary Shares - Class A (NUVB) - Nuvation Bio Inc - Expect to Submit Up to Five Additional Investigational NDA With the U.S. FDA by 2026.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.11

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.12

More details on our Analysts Page.